openPR Logo
Press release

Drug Rescue Market Estimated to Flourish by 2024

01-03-2018 11:02 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research

Drug rescue is also termed as rescue medicines. These are given only when needed or in emergency cases. Drug which is given to counter or block the effect of other medicines are called as rescue medicines. Rescue medications are often used for asthma, in chemotherapy, in severe allergies, in epilepsy, etc. These are fast acting or quick acting medications. Rescue medicines are used in severe asthma attack, migraine attack, or in severe allergy reaction and help to save lives. In clinical trials, rescue medicines are given with a drug to control the alleviated symptoms of the study treatment or lack of disease efficiency. The effect of rescue drugs are not long lasting, but these quickly stop the symptoms of study drug.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/drug-rescue-market.html

The drug rescue market has been segmented based on drug class, indication, route of administration, and distribution channel. In terms of drug class, the market has been segmented into antiepileptics, analgesics, antinauseants, muscle relaxants, and bronchodilators.

Based on indication, the drug rescue market has been categorized into asthma, migraine, epilepsy, cancer, hypertension, cardiac attack, and others. Rescue medicines prevent asthma attack quickly. Bronchodilators are the generally used medication in asthma. Bronchodilators help open the airways by dilating the bronchi and enable a patient to breathe more easily. Migraine is another medical condition where rescue medications are widely used. Migraine attacks are disabling and severe. Several over-the-counter or prescription medicines are available to stop a migraine attack. Ibuprofen or acetaminophen or drugs containing caffeine are the most common rescue medicines for migraine.

Download Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20807

Benzodiazepines are the most common rescue medicines for seizures or epilepsy attack. Benzodiazepine is a fast acting drug and starts work quickly once it gets into the bloodstream to prevent seizures. Benzodiazepines are available in different forms such chewing pills, oral tablet, or nasal sprays. The most common benzodiazepines used as rescue medications are diazepam, lorazepam, and midazolam. Intravenous treatment is given in hypertension and cardiac emergencies. These directly go into the bloodstream and 100% bioavailability can be achieved by intravenous route. Sodium nitroprusside, nitroglycerin, labetalol, and nicardipine are the commonly used drugs for hypertension.

In terms of route of administration, the drug rescue market has been segmented into oral, parenteral, sublingual, nasal, and rectal. Nasal route is the widely used route of administration for asthma and epilepsy attacks. Drugs given through nasal route have fast effect. The smaller mist particles directly go in systemic circulation and act quickly. Intravenous route is given in severe conditions when other route of administration do not work.

Based on distribution channel, the drug rescue market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies is widely used distribution channel as many over-the-counter rescue drugs are also available. Growth of the online pharmacies segment is likely to boost the market during the forecast period.

In terms of region, the drug rescue market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the major share of the drug rescue market owing to increasing incidence of severe and chronic medical conditions. The rising geriatric population is also anticipated to boost the growth of the market during the forecast period. Asia Pacific is the most progressive region for the drug rescue market due to increasing over-the-counter rescue medicines in the region.

Major factor boosting the growth of this market include rising demand for quick treatment for severe medical conditions. However, the increasing side effects of rescue medicines is likely to restrain the drug rescue market. Major players in the drug rescue market are Bioneer Corporation, VistaGen Therapeutics, Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industry Ltd., Merck & Co., Inc., and UCB Group of Companies.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=20807<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Rescue Market Estimated to Flourish by 2024 here

News-ID: 883011 • Views:

More Releases from Transparency Market Research

Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnostic Advancements, Oral Drug Innovations, and Rising Disease Awareness | TMR
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035. Gain a preview of important insights from
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, AI/ML Bioinformatics and Portable DNA Devices Transform Criminal Investigations | TMR
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035. Access key findings
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for High-Load, High-Precision Actuation Systems Accelerates Worldwide | TMR
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven by Sustainability Initiatives, Regulatory Compliance, and Rising Industrial Demand
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Access key

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase